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Abstract 
Coronavirus disease 2019 (COVID-19) outbreak has created a great challenge 
for the healthcare system worldwide. One of the most critical points of this 
challenge is the management of COVID-19 patients needing acute and/or 
critical respiratory care. This study was performed to discover an AI based 
model to improve the critical care of the COVID-19 patients. In a descriptive 
study, all the published research available in PubMed, Web of Science, Google 
scholar and other databases were retrieved. Based on these studies, a three 
stage model of input, process and output was created. Three stages model of 
AI application in intensive care unit (ICU) was completed. Input included 
clinical, paraclinical, personalized medicine (OMICS) and epidemiologic data. 
The process included artificial intelligence (i.e. artificial neural network, 
machine learning, deep learning and expert systems). The output which was 
ICU decision making included diagnosis, treatment, risk stratification, 
prognosis and management. Efforts of the healthcare system to defeat COVID-
19 could be supported by an AI-based decision-making system which would 
double them up and help manage these patients much more efficiently, 
especially those in COVID-19 ICU. 
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Introduction 
The coronavirus (SARS-CoV-2) infection 
outbreak started in December 2019 (COVID-19) in 
Wuhan, China; the aftermath worldwide pandemic 
with its fast outbreak has created an extraordinary 
challenge to the world in the 21st century (1, 2). The 
problem has many unique and even unknown features 
that human being has never been faced with (3-5).  
COVID-19 mortality rate (MR) and case fatality 
rate (CFR) depend on a few numbers of important 
factors; among them, the care of the critical patients is 
one of the most important ones (6). Therefore, one of 
the most critical points of this challenge is the 
management of COVID-19 patients needing acute 
and/or critical respiratory care. 
How can we manage the critical care of the 
COVID-19 patients using AI? Consider the scene in an 
intensive care unit (ICU) with several COVID-19 
patients; some are intubated while others possibly 
receiving noninvasive ventilation while doctors and 
nurses challenge the virus in personal protection 
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equipment and a percentage of them have been 
exhausted. Add to this fact, the potential several fold 
demand for ICU beds at the doors of the ward and the 
quality of care which is a direct function of the 
performance in ICU wards in each country and the 
resulting worldwide outcome.  
However, after a couple of months, human 
being has started novel approaches to manage this 
challenge (7-10). Many would suggest that artificial 
intelligence (AI) would be one of the most efficient 
potential arsenals. Nevertheless, how it could help us? 
The role of AI in such a dynamic atmosphere needs to 
be an innovative one; otherwise the process of patient 
care and clinical decision making would be disturbed 
(11-13).  
A few studies have reviewed AI role in COVID-
19 ICU patients. The aim of this study was to assess 
the role of Artificial Intelligence in management of 
critical COVID-19 patients. This study was performed 
to discover an AI based model to improve the critical 
care of the COVID-19 patients. 
Methods 
The study proposal was assessed and approved 
by Research Ethics Committee, Shahid Beheshti 
University of Medical Sciences, Tehran, Iran; coded: 
IR.SBMU.RETECH.REC.1399.018.  
The search strategy was based on the following 
items: 
Search topic: studies on use of artificial intelligence in 
ICU regarding respiratory diseases specially COVID-
19 management 
Search engines: PubMed, Web of Science, Google 
scholar, the other databases according to its user guide 
Hand search: yes; for two specialized journals on 
public health topic: "JMIR Public Health and 
Surveillance" and "Lancet Digital health" 
Search terms: MeSH terms and keywords related to 
AI, ICU, COVID-19 and lung diseases 
Second order search: the references of the retrieved 
articles in the search results were screened for 
potentially relevant studies 
Publication date search limit: no time limitation on 
publication date was applied 
MeSH words for search: included the following: 
(COVID-19[Title/Abstract]) AND artificial 
intelligence[Title/Abstract] OR 
(MERS[Title/Abstract]) AND artificial 
intelligence[Title/Abstract] AND artificial 
intelligence[Title/Abstract] OR (lung[Title/Abstract]) 
AND artificial intelligence[Title/Abstract] AND 
artificial intelligence[Title/Abstract] OR 
(respiratory[Title/Abstract]) AND artificial 
intelligence[Title/Abstract] AND artificial 
intelligence[Title/Abstract] OR ((("Respiration, 
Artificial"[Mesh]) AND ICU [Title/Abstract])) AND 
artificial intelligence[Title] 
After completion of the search, 3 stages process 
of input, process and output was developed and the 
search results were categorized in one of the 3 stages; 
this model was based on the methods of previous 
studies (8, 12-20). 
Results 
Based on three stages model of input, process 
and output of this study, the main current AI 
applications in COVID-19 pandemic are listed; this 
model aims to improve the critical care of COVID-19 
patients; each of three stages are divided to 
subcategories (Figure 1 & Table 1). 
Discusion 
Developing an AI models to predict whether a 
patient have a high risk of having a health crisis or not 
based on specific information from the patients is 
possible. Moreover, creating software services, which 
can automatically categorize the risk of crisis on 
different patients, is considered as a solution to have a 
personalized medicine (21, 22). Furthermore, reducing 
frequent lab testing and the potential clinical and 
financial implications are an important issue in ICU, 
which an AI can predict the laboratory tests with high 
accuracy and in predicting the probable information 
(23). Further, various surveillance systems have been 
developed to monitor the emergence of respiratory-
tract infections (19). 
Those items that could be categorized under 
Input are briefed here.  
Clinical Symptoms and signs of COVID-19 
could be flagged before clinicians discover them; this 
is an alarming property of AI. In fact, if clinicians 
could discover the symptoms with a considerable time 
interval, the facilities for detection of the high-risk 
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patients would be more available (11). 
Epidemiological aspects of viral spread, which 
could be detected and predicted using data mining 
approaches. Using this method, flagging epidemics 
before health authorities discover them would be an 
attractive and beneficial option. In addition, defining 
hot points and the emerging epicenters using data 
mining approaches, air traffic maps, mobile phone 
contacts, social media data, etc. would be an easily 
done task (10, 24-29). Another point of view is the AI 
assisted approaches used for defining the patterns of 
community spread and foretelling the possible effects 
of the health interventions on the next steps of the 
outbreak (8, 28, 29). During COVID-19 outbreak in 
China, active case finding through mobile phones was 
an effective approach to limit the epidemic; which was 
an AI-based method (10). 
AI could boost personalized medicine; when AI 
could potentially identify the most susceptible people 
based on personalized genetic & physiological 
characteristics (27, 28, 30). Add to the above, the role 
of AI (including but not limited to machine learning, 
deep learning, etc.) in personalized medicine and 
genomics, epigenetics, transcriptomics, proteomics, 
metabolomics and other multi-OMICS (30-34). The 
genomic studies of COVID-19 for assessing the 8 
subtypes of the virus are AI-backed processes which 
are discussed under the website https://nextstrain.org; 
all these approaches lead to discover novel diagnostics 
and therapeutics; which are also, part of the output (35, 
36).  
Regarding process, the following items could be 
briefed as follows. In differential diagnosis of COVID-
19 from other types of Community acquired 
pneumonia, deep learning (deep structured learning) 
could be a very useful tool. On the other hand, machine 
learning analysis of genetic variants from 
asymptomatic, mild or severe COVID-19 patients can 
be performed to classify and predict potential patients; 
this approach would be performed based on the 
vulnerability or resistance of patients to potential 
COVID-19 infection; which is a "deep learning-based" 
approach (8, 10, 11, 28, 29). Another study showed that 
AI based monitoring of critically ill patients is 
associated with especial focus on pervasive sensing 
and deep learning system (37). Other approaches like 
using AI for improving risk communication strategies 
in the affected population using Google Trends is 
another approach which could be based on timing of 
and defining the location of the patients (29). 
Regarding output the following items could be 
mentioned. Diagnostic approaches: COVID-19 is a 
systemic disease with its most severe and lethal 
complications occurring in the lungs; however, like 
any other disease, before starting treatment, a 
definitive diagnosis is mandatory which relies on 
history, physical examination and paraclinical data. 
Chest CT scan remains one of the most sensitive 
items; even more than RT-PCR tests from deep 
nasotracheal samples (38, 39). Add to the above, 
further improvements in diagnostic speed and 
accuracy of the tests including the role of CRISPR-
based COVID-19 detection assay which are 
supplementary methods of detection (40). An AI 
Table 1- A three stage model of AI application in ICU (8, 12-20). 
 
Input  Clinical data 
 Paraclinical data 
 Personalized Medicine (OMICS) data 
 Epidemiologic data 
Process  Artificial Intelligence: 
1. Artificial Neural Network 
2. Machine Learning & Deep Learning 
3. Expert Systems 
Output  ICU Decision Making 
1. Diagnosis 
2. Treatment 
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system can also analyze the efficacy of diagnostic 
lab tests and so, improve the efficiency of the 
critical care in ICU (23).  
Based on previous experiences, Therapeutic 
approaches for COVID-19 patients would be 
improved by the help of AI-based methods. One of the 
challenges in ICU patients is the algorithm for 
management and early detection of patients who may 
undergo prolonged mechanical ventilation and 
tracheostomy; AI has created an effective solution for 
it (41). Besides, for patients with difficult airway, AI 
has created novel approaches based on the Random 
Forest algorithm to predict and manage difficult airway 
(42-45). Some other examples include the in silico 
pharmacological methods used for drug redesign or 
drug repurposing or at times for designing novel drugs 
and/or discovering potential drug candidates 
specifically against SARS-CoV-2 or even repurposing 
clinically-approved drugs to overcome SARS-CoV-2 
(9, 46, 47). During the current era, a challenge in 
healthcare systems all over the world is to produce 
COVID-19 vaccine; a newly developed Vaxign reverse 
vaccinology tool integrated with machine learning has 
proposed candidates. In silico models of vaccine 
production (like vaccine investigation and online 
information network: VIOLIN; 
http://www.violinet.org) have been claimed useful 
which rely on AI, databases and in silico tools (47-50). 
Whenever the care of ICU patients is discussed, 
an important aspect is the difficulties in the decision-
making processes; AI and related mechanisms could 
enable us make more efficient decisions. This starts 
from risk stratification, diagnostic data, prognosis & 
survival trends, risk classification, risk prediction and 
finally survival prediction; all of them would be 
appropriate for COVID-19 patients. During the 
outbreaks, ICU management for bed allocation 
becomes an important issue with great ethical aspects; 
AI could help us decide in a cost-effective manner 
while considering ethics. Add to the above, the 
healthcare personal protection issues which could be 
improved using AI approaches (8, 11-13, 28).  
The challenge in managing COVID-19 patients 
admitted to ICU in critical condition is a new model of 
an old problem. Patients admitted to the ICU often 
receive multiple concurrent therapies due to their 
condition, and at the same time, there is usually lack of 
sufficient and strong guidelines; which has made 
physicians' decisions largely dependent on personal 
knowledge, experience and commonsense (14). 
 
Figure 1. A three stage model of AI application in ICU (8, 12-20). 
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However, AI is capable of finding complex 
relationships in a large volume of data with 
simultaneous rapid analysis of a large databank and 
complex variables. Finally, answering difficult 
questions with good validity and reliability like the 
chance of survival in sepsis in each individual patient, 
using AI and AI-based methods would make it more 
probable to overcome these complexes and multilateral 
problems. This is why a large number of studies in the 
field of pulmonary infectious diseases and other 
respiratory problems and in the management of ICU 
patients have demonstrated that the application of AI 
could be an effective approach in this setting (12-16). 
Critical care practitioners are often need making 
critical decisions based on large volumes of complex 
and heterogeneous data. AI, if used effectively, can 
reduce this complexity by converting data into relevant 
information (16-18, 22, 23, 49). Besides, AI has been 
demonstrated to have a determining role in diagnosis 
of obstructive lung disease and respiratory infectious 
disease (51). However, large-scale studies are still 
required to validate these findings and to increase their 
acceptance by the medical community. From another 
point of view, errors in medicine, which are very 
costly, could be largely preventable with the help of AI 
and Machine Learning. Of particular interest is the role 
of AI in decision making; especially when sufficient 
and/or conclusive evidence are not available (52). 
Deep learning architectures are widely used in 
forecasting, classification and bioinformatics and are 
recognized as a powerful tool for infectious disease 
analysis (53). 
The use of artificial neural networks to design a 
model for automatic classification of respiratory crisis 
patients has yielded in brilliant results (54-56). This 
technology can also be used to monitor the trend of 
care and therapy in ICU so that the following aspects 
would be tangible in clinical practice (37): 
 face detection 
 face recognition 
 facial action unit detection 
 facial expression recognition 
 posture recognition 
 extremity movement analysis 
 sound pressure level detection 
 light level detection to realize 
 visitation frequency detection  
To better manage patients with COVID-19 
admitted to the ICU, the use of medical assisted 
decision systems (CDSS) or artificial intelligence-
based reasoning engines will assist the decision-
making team. The design of this argument engine 
requires the availability of accurate and comprehensive 
data. Collecting and storing data on COVID-19 
patients is very important in this regard. In this regard, 
the existence of COVID-19 disease registry systems is 
essential. Now, since most countries' health systems 
focus on control of the epidemic and treatment of 
patients, and on the manufacturing and production of 
drugs and vaccines, attention has been given to the 
design and implementation of a rapid, yet accurate and 
complete registry system related to the disease. 
However, the efforts of the healthcare system to defeat 
COVID-19 could be supported by an AI-based 
decision-making system which would double them up 
and help manage these patients much more efficiently, 
especially those in COVID-19 ICU. 
Conclusion    
Efforts of the healthcare system to defeat 
COVID-19 could be supported by an AI-based 
decision-making system which would double them up 
and help manage these patients much more efficiently, 
especially those in COVID-19 ICU. 
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